Our Deals
Deals
GSK Sold Assets to Crown Laboratories
Overview
GlaxoSmithKline PLC (GSK) is a global pharmaceutical development, manufacturing, and marketing company. GSK sold five branded assets to Crown Laboratories a portfolio company of Hildred Capital Partners LLC. Financial terms of the transaction weren’t disclosed.
Significance
This transaction will provide Crown Laboratories with broader portfolio of differentiated branded product.
Crosstree’s Role
Crosstree served as sole advisor to GlaxoSmithKline PLC (GSK).
Type
Merger and Acquisition
Deal Tags
Healthcare